Translational Biology Partner for Lean Biotech Teams
Turning complex biology, CRO execution, and early R&D data into actionable development decisions.
Your CRO can execute the work.
Your program still needs someone on your side protecting the biological question.
Practical entry points
Study Plan Pressure Test
CRO Proposal / SOW Review
Assay Strategy Session
Preclinical Study Risk Check
Ongoing Fractional Biology Support
Built for founders who need senior biology judgement and CRO fluency.
Polaris BioStrategy is led by Rachel Wang, Ph.D., a translational immunologist with hands-on experience across functional assays, flow cytometry, immuno-oncology, autoimmunity, T cell engagers, bispecifics, ADCs, and CRO-executable study design. Rachel has worked across the full CRO interface — as a biology SME, scientific advisor, and study director— giving Polaris firsthand insight into how studies are scoped, launched, executed, delayed, troubleshot, reported, and translated into program decisions.